|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Freeline Therapeutics (NASDAQ: FRLN) through any online brokerage.
There are no as such competitors for Freeline Therapeutics.
The latest price target for Freeline Therapeutics (NASDAQ: FRLN) was reported by HC Wainwright & Co. on May 19, 2021. The analyst firm set a price target for 30.00 expecting FRLN to rise to within 12 months (a possible 250.88% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Freeline Therapeutics (NASDAQ: FRLN) is $8.55 last updated Wed Jun 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Freeline Therapeutics.
Freeline Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Freeline Therapeutics.
Freeline Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.